Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Verisk Reports Second Quarter 2026 Financial Results
-
Momcozy Announces Breastfeeding Month Deals Across Feeding, Nursing and Baby Care
-
Interest in Disability Insurance for Veterinarians Triples in 12 Months
-
uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update
-
Anika Reports Second Quarter 2026 Financial Results
-
Kornit Digital Sets Second Quarter 2026 Earnings Release Date and Webcast
-
Axogen, Inc. Reports Second Quarter 2026 Financial Results
-
Form 8.3 - Brave Bison Group Plc
-
First Northwest Bancorp Reports Second Quarter 2026 Financial Results
-
Ocugen Announces that the U.S. Food and Drug Administration Has Granted OCU410 Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Geographic Atrophy, Secondary to Dry Age-Relat
-
Form 8.3 - Animalcare Group Plc
-
Freehand Raises $75M to Scale AI Teams Managing Supply Chain Spend for Fortune 500 Companies
-
Snapmaker Leverages Aurora Mobile's EngageLab to Achieve Highly Efficient Global User Reach
-
Sable Announces Share Consolidation
-
Surge Copper Announces Board Renewal and Director Nominees for 2026 Annual General Meeting
-
Lightbridge Corporation Added to the Solactive Global Uranium & Nuclear Components Total Return Index, the Benchmark Tracked by the Global X Uranium ETF (URA)
-
AmpliTech Group Secures More Than $6 Million in Follow-On Orders During The Month Of July 2026
-
OPSEU/SEFPO workers at Canadian Blood Services strike a blow against privatization
-
The Chefs’ Warehouse Reports Second Quarter 2026 Financial Results
-
XORTX Appoints New Director
-
Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026
-
Atavistik Bio Appoints Habib Dable to its Board of Directors
-
ADMA Biologics to Report Second Quarter 2026 Financial Results on August 5, 2026
-
Capital Clean Energy Carriers Corp. Announces Second Quarter 2026 Financial Results
-
Snapmaker Leverages Aurora Mobile's EngageLab to Achieve Highly Efficient Global User Reach
-
TRUE-See Systems Announces New Venture Funding
-
TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2™, a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies
-
Amarin Reports 2026 Second Quarter Financial Results Demonstrating Early Success of Fully Partnered International Commercial Strategy and Continued Leading U.S. Market Presence
-
Bioxytran Announces Publication of Corporate Research Report by Globe Small Cap Research
-
Kirby Corporation Announces Second Quarter 2026 Results
-
Lumexa Imaging Announces Second Quarter 2026 Earnings Conference Call Date
-
Energous’ PowerBridge Pro+ Receives FCC Certification, Advancing Commercialization of the Company’s End-to-End Wireless Power Solution
-
Factorial and SK On Sign MoU to Explore Solid-State Battery Manufacturing
-
Capital Power reports second quarter 2026 results
-
LEO Technologies Launches Verus Vision AI, Transforming Correctional Cameras into Active Operational Intelligence
-
Dynamis Power Solutions Awards Baker Hughes Major Power Generation Order for Data Centers, Oil & Gas
-
Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe
-
GXO To Ring NYSE Opening Bell To Celebrate Fifth Anniversary
-
Capital Bank Appoints Jay Como as Chief Operating Officer
-
Global Energy Technology Company Siemens Energy AG Begins Trading on OTCQX Best Market
-
Shenandoah Telecommunications Company Reports Second Quarter 2026 Results
-
VisionWave Files U.S. Non-Provisional Patent Application for DeepWave RF™, an AI-Powered Subsurface Sensing and Visualization Platform
-
Option Care Health Announces Financial Results For The Second Quarter Ended June 30, 2026
-
Dynamis Power Solutions Awards Baker Hughes Major Power Generation Order for Data Centers, Oil & Gas
-
Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET
-
Form 8.3 - Ramsdens Holdings Plc
-
Bull DeFi Announces Platform Milestone and Expanded Global Computing Infrastructure
-
Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy
-
Silexion Therapeutics Successfully Initiates Phase 2/3 Clinical Trial of SIL204 in Locally Advanced Pancreatic Cancer at Tel Aviv Sourasky Medical Center
-
VERAXA Biotech Strengthens Patent Portfolio to Protect Core Technology Platforms and Product Candidates
